Letters
Hepatitis B, lamivudine, and HIV
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7303.51 (Published 07 July 2001) Cite this as: BMJ 2001;323:51
- Usha Kuchimanchi (kuchimanchi@doctors.org.uk), specialist registrar,
- Guy Rooney, consultant physician
- Department of Genitourinary Medicine, Radcliffe Infirmary, Oxford OX2 6HE
- Department of Genitourinary Medicine, Princess Margaret Hospital, Swindon SN1 4JU
EDITOR—Ryder and Beckingham reviewed the management and treatment of chronic viral hepatitis.1 Lamivudine has a good safety profile and has been shown to be beneficial for patients requiring treatment for hepatitis B infection. It …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.